San Francisco, CA · Founded 2023 · Privately Held (backing)
Operator of a clinical-stage, next-generation gene correction company intended to cure serious and life-threatening diseases. Kamau Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $48.5 million at its seed round in Jun 2025, the last priced event on record. It has raised $31.8 million across 1 recorded round; the latest was a $5 million seed round in May 2025.
PMV mark · valuation
$48.5M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$31.8M
Last round
Seed Round
May 2025
Cap table — not yet on record
Kamau Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kamau Therapeutics with a free account
·Watch Kamau Therapeutics: the Monday email on marks, rounds and moves
Where does Kamau Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Kamau Therapeutics's 1 recorded funding rounds.
